PorOsteon’s Phusion Metal Cervical Cage receives FDA approval

PorOsteon received 510(k) clearance from the U.S. Food and Drug Administration to market its new Phusion Metal Cervical Cage.

Advertisement

The device is designed to maximize bone growth through a fully interconnected porous structure and matching the modulus of living cancellous bone. It is indicated for intervertebral body fusion of the spine in adult patients. The cervical cage is the first of a family of surgical devices taking advantage of the unique properties of Phusion Metal.

 

PorOsteon is a privately-held company focused on developing its proprietary Nitinol-based Phusion Metal for a wide range of musculoskeletal indications.

More articles on devices:

Inside orthopedic, spine device companies — 3 stock transactions
Benvenue Medical names Rick Simmons VP of sales & marketing
Dr. Daniel Le is uses 1st HipSextant Navigation system in Houston

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • SurGenTec’s ION-C earned FDA 510(k) clearance for ION-C navigation instruments with the ION-C posterior cervical facet fixation implant, according to…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.